Treatment evolution for metastatic castration‐resistant prostate cancer with recent introduction of novel agents: retrospective analysis of real‐world data-Reference-Cited by-同舟云学术

Treatment evolution for metastatic castration‐resistant prostate cancer with recent introduction of novel agents: retrospective analysis of real‐world data

Published:2015-12-29 Issue:2 Volume:5 Page:182-191
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Med

Author:

Flaig Thomas W.¹,Potluri Ravi C.²,Ng Yvette³,Todd Mary B.³,Mehra Maneesha⁴

Affiliation:

1. University of Colorado Cancer Center Medical Oncology Aurora Colorado

2. Smart Analyst Inc. New York New York

3. Janssen Global Services Global Medical Affairs Raritan New Jersey

4. Janssen Global Services Global Market Access Analytics Raritan New Jersey

Funder

Janssen Research and Development

Genentech

Novartis

Sanofi

Publisher

Wiley

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.576

Reference30 articles.

1. Leuprolide: a review of its effects in comparison with diethylstilboestrol in the treatment of advanced cancer of the prostate;Garnick M. B.;Br. J. Clin. Pract.,1985

2. Progress in emerging therapies for advanced prostate cancer

3. Secondary Hormonal Therapy for Advanced Prostate Cancer

4. Chemotherapy with mitoxantrone plus prednisone or prednisone alone for symptomatic hormone-resistant prostate cancer: a Canadian randomized trial with palliative end points.

5. Docetaxel and Estramustine Compared with Mitoxantrone and Prednisone for Advanced Refractory Prostate Cancer

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Revolutionizing of bioactive natural products in prostate cancer research and care: Promising discoveries and future directions;Intelligent Pharmacy;2024-07

2. Real-world treatment patterns and medical costs of prostate cancer patients in Switzerland – A claims data analysis;European Journal of Cancer;2024-06

3. Impact of DNA damage repair alterations on prostate cancer progression and metastasis;Frontiers in Oncology;2023-06-26

5. First-line treatment of metastatic castration-resistant prostate cancer: the real-world Italian cohort of the Prostate Cancer Registry;Tumori Journal;2022-04-09